AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Nov 14, 2025
31676_dirs_2025-11-14_0c7237dd-dce5-4453-941f-c82f38d3f09e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-11-12
Reporting Person: Gassert Chad (SVP - CORP. DEV. & STRATEGY)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Common Stock | S | 14642 | $89.07 | Disposed | 158584 | Indirect |
| 2025-11-13 | Common Stock | S | 94 | $88 | Disposed | 158490 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 73615 | Direct |
Footnotes
F1: The shares were sold in multiple trades at prices ranging from $89.00 to $89.50. The price reported above reflects the weighted average sales price.
F2: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3